Want to join the conversation?
Stephens analyst Rick Patel questions $OXM whether sales on Tommy Bahama being up high-single digits and Lilly up low-single digits were 2Q16 guidance sales or same-store sales. CEO Thomas Chubb says that was being referred in regards to 2Q16 sales projection. CFO Scott Grassmyer also says that $OXM is expecting a negative 2Q16 comp in Lilly.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)